Lumida
/SDGR
⌘K
Schrodinger Inc

Schrodinger Inc

SDGR
$19.02USD+1.17%+0.22 today

MARKET CAP

1.4B

P/E (TTM)

FWD P/E

DAY RANGE

$19 – $19

52W RANGE

$11
$23

AI Summary

Stalk
Sell NowMedium

SDGR has broken key early-September consolidation support, closing below the rising 9EMA and 20EMA, signaling that buyers can no longer absorb supply and suggesting potential for accelerated downside. Medium-term bias shifts to bearish given the Support Failure pattern, and short-term timing is unfavorable with rejection at EMAs. Execution focuses on sell-side participation into any bounce toward the former support zone near mid-19s, with invalidation on a reclaim and acceptance back above the 9EMA/20EMA area.

  • ACV up 27% YoY to $29.6M; FY ACV guide $218–228M
  • Q2 total revenue $58.9M; drug discovery rev rose to $23M
  • Negative earnings yield and weak profitability factors signal low returns
Full analysis →
Insider Trades33 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Jul 16, 2026SellSDGRRachit JainEVP & CFO875$15.60$1.4B-17.38%+73.78%$13.6K-1.69%10b5-1Trim
Apr 16, 2026SellSDGRRachit JainEVP & CFO844$12.75$1.4B-17.38%+73.78%$10.8K-1.60%10b5-1Trim
Apr 16, 2026BuySDGRRamy FaridPresident & CEO246,527$6.28$1.4B-17.38%+73.78%$1.5M+3.86%10b5-1Trim
Mar 5, 2026SellSDGRYvonne TranEVP, CLO & CPO1,094$12.89$1.4B-17.38%+73.78%$14.1K-2.03%10b5-1Trim
Mar 5, 2026SellSDGRKenneth Patrick LortonEVP, CTO & COO, Software1,222$12.90$1.4B-17.38%+73.78%$15.8K-1.35%10b5-1Trim
Mar 5, 2026SellSDGRKaren Akinsanya1,366$12.90$1.4B-17.38%+73.78%$17.6K-1.92%10b5-1Trim
Mar 5, 2026SellSDGRJenny HermanCAO1,383$12.84$1.4B-17.38%+73.78%$17.8K-1.93%10b5-1Trim
Mar 5, 2026SellSDGRRachit JainEVP & CFO1,631$12.90$1.4B-17.38%+73.78%$21.0K-3.01%10b5-1Trim
Mar 5, 2026SellSDGRRamy FaridPresident & CEO3,661$12.91$1.4B-17.38%+73.78%$47.2K-1.09%10b5-1Trim
Mar 4, 2026SellSDGRRobert Lorne Abel1,300$12.81$1.4B-17.38%+73.78%$16.7K-2.27%10b5-1Trim
Mar 2, 2026SellSDGRKaren Akinsanya2,206$11.99$1.4B-17.38%+73.78%$26.5K-1.81%10b5-1Trim
Mar 2, 2026SellSDGRRamy FaridPresident & CEO5,560$11.90$1.4B-17.38%+73.78%$66.2K-1.23%10b5-1Trim
Feb 10, 2026SellSDGRJenny HermanCAO752$13.79$1.4B-17.38%+73.78%$10.4K-2.75%10b5-1Trim
Feb 10, 2026SellSDGRYvonne TranEVP, CLO & CPO776$13.80$1.4B-17.38%+73.78%$10.7K-3.28%10b5-1Trim
Feb 10, 2026SellSDGRKenneth Patrick LortonEVP, CTO & COO, Software925$13.73$1.4B-17.38%+73.78%$12.7K-1.73%10b5-1Trim
Feb 9, 2026SellSDGRRobert Lorne Abel1,230$13.51$1.4B-17.38%+73.78%$16.6K-5.97%10b5-1Trim
Oct 16, 2025SellSDGRMargaret DuganChief Medical Officer1,395$21.07$1.4B-17.38%+73.78%$29.4K-5.37%10b5-1Trim
Apr 14, 2025SellSDGRKaren AkinsanyaPresident of R&D, Therapeutics33,446$14.12$1.4B-17.38%+73.78%$472.4K+0.00%10b5-1Trim
Mar 6, 2025SellSDGRJenny HermanSVP & Controller666$21.11$1.4B-17.38%+73.78%$14.1K-2.38%10b5-1Trim
Mar 3, 2025SellSDGRGeoffrey Craig PorgesEVP & CFO5,491$21.76$1.4B-17.38%+73.78%$119.5K-6.61%10b5-1Trim
Feb 18, 2025SellSDGRYvonne TranEVP, CLO & CPO7,804$16.17$1.4B-17.38%+73.78%$126.2K+0.00%10b5-1Trim
Feb 11, 2025SellSDGRYvonne TranEVP, CLO & CPO828$24.43$1.4B-17.38%+73.78%$20.2K-6.92%10b5-1Trim
Feb 11, 2025SellSDGRJenny HermanSVP & Controller859$24.43$1.4B-17.38%+73.78%$21.0K-4.50%10b5-1Trim
Feb 11, 2025SellSDGRKenneth Patrick LortonEVP, CTO & COO, Software985$24.43$1.4B-17.38%+73.78%$24.1K-2.34%10b5-1Trim
Feb 10, 2025SellSDGRRobert Lorne Abel1,225$25.99$1.4B-17.38%+73.78%$31.8K-13.12%10b5-1Trim
Oct 15, 2024SellSDGRMargaret DuganChief Medical Officer1,531$17.78$1.4B-17.38%+73.78%$27.2K-10.21%10b5-1Trim
Mar 6, 2024BuySDGRKenneth Patrick LortonEVP, CTO & COO, Software5,574$4.34$1.4B-17.38%+73.78%$24.2K+15.28%Trim
Mar 4, 2024SellSDGRGeoffrey Craig PorgesEVP & CFO3,315$26.35$1.4B-17.38%+73.78%$87.4K-3.35%10b5-1Trim
Feb 12, 2024SellSDGRYvonne TranEVP, CLO & CPO758$28.29$1.4B-17.38%+73.78%$21.4K-5.96%10b5-1Trim
Feb 12, 2024SellSDGRJenny HermanSVP & Controller787$28.29$1.4B-17.38%+73.78%$22.3K-6.27%10b5-1Trim
Feb 12, 2024SellSDGRKenneth Patrick LortonEVP, CTO & COO, Software901$28.29$1.4B-17.38%+73.78%$25.5K-2.41%10b5-1Trim
Feb 12, 2024SellSDGRRobert Lorne Abel1,205$27.55$1.4B-17.38%+73.78%$33.2K-11.43%10b5-1Trim
Sep 15, 2023BuySDGRJenny HermanSVP & Controller4,545$1.20$1.4B-17.38%+73.78%$5.5K+56.79%Trim